Scarica l'app Stockscreener
30.00
2.04%
0.60
Dopo l'orario di chiusura:
29.96
-0.04
-0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALKS Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$29.40
Aprire:
$29.86
Volume 24 ore:
3.09M
Relative Volume:
1.78
Capitalizzazione di mercato:
$4.95B
Reddito:
$1.51B
Utile/perdita netta:
$333.35M
Rapporto P/E:
15.38
EPS:
1.95
Flusso di cassa netto:
$315.22M
1 W Prestazione:
+2.56%
1M Prestazione:
+12.99%
6M Prestazione:
-12.05%
1 anno Prestazione:
+6.69%
Intervallo 1D:
$29.66
$31.69
Intervallo di 1 settimana:
$28.77
$31.69
Portata 52W:
$25.56
$36.45
Alkermes Plc Stock (ALKS) Company Profile
Nome
Alkermes Plc
Settore
Telefono
00-353-1-772-8000
Indirizzo
CONNAUGHT HOUSE, DUBLIN 4
Confronta ALKS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALKS
Alkermes Plc
|
30.00 | 4.85B | 1.51B | 333.35M | 315.22M | 1.95 |
|
ZTS
Zoetis Inc
|
152.43 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.15 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.89 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.76 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
391.45 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Alkermes Plc Stock (ALKS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Iniziato | Goldman | Buy |
| 2025-06-17 | Aggiornamento | UBS | Neutral → Buy |
| 2025-05-28 | Iniziato | Needham | Buy |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-03-04 | Aggiornamento | UBS | Sell → Neutral |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-11-05 | Aggiornamento | Stifel | Hold → Buy |
| 2024-06-17 | Iniziato | TD Cowen | Buy |
| 2024-03-19 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-20 | Downgrade | UBS | Neutral → Sell |
| 2023-11-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-24 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-10-17 | Iniziato | UBS | Neutral |
| 2022-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-10-14 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-16 | Iniziato | Piper Sandler | Neutral |
| 2022-04-22 | Ripresa | Goldman | Buy |
| 2022-04-20 | Iniziato | Goldman | Buy |
| 2022-01-27 | Aggiornamento | Cantor Fitzgerald | Hold → Overweight |
| 2021-12-01 | Iniziato | Citigroup | Neutral |
| 2021-10-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-09-02 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-10-15 | Aggiornamento | Mizuho | Neutral → Buy |
| 2020-07-30 | Downgrade | Goldman | Neutral → Sell |
| 2020-02-14 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-02-14 | Reiterato | H.C. Wainwright | Neutral |
| 2020-02-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-02-06 | Iniziato | Mizuho | Neutral |
| 2020-01-31 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2019-09-05 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-07-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2019-05-31 | Iniziato | H.C. Wainwright | Neutral |
| 2019-05-01 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Downgrade | Goldman | Neutral → Sell |
| 2018-12-14 | Iniziato | Wolfe Research | Underperform |
| 2018-12-13 | Downgrade | Credit Suisse | Outperform → Underperform |
| 2018-11-05 | Iniziato | Piper Jaffray | Neutral |
| 2018-08-07 | Iniziato | Stifel | Hold |
| 2018-06-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-06-06 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2018-05-16 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-05-11 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Alkermes Plc Borsa (ALKS) Ultime notizie
What analysts say about Alkermes plc stockQuarterly Investment Review & Free High Return Stock Watch Alerts - khodrobank.com
Does Alkermes plc show high probability of rebound2025 Price Targets & Breakout Confirmation Trade Signals - Newser
What machine learning models say about Alkermes plcJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - Newser
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On WednesdayCogent Biosciences (NASDAQ:COGT), Alkermes (NASDAQ:ALKS) - Benzinga
This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Nanotechnology Drug Delivery Market Outlook (2025-2032) : - openPR.com
Wells Fargo Initiates Alkermes Public at Overweight With $44 Price Target - MarketScreener
Applying sector rotation models to Alkermes plcNew Guidance & Free Safe Entry Trade Signal Reports - Newser
Real time alert setup for Alkermes plc performanceBond Market & AI Driven Stock Movement Reports - Newser
How to integrate Alkermes plc into portfolio analysis toolsPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Will a bounce in Alkermes plc offer an exitQuarterly Market Review & Smart Allocation Stock Tips - Newser
How to use a screener to detect Alkermes plc breakouts2025 Top Gainers & Verified Momentum Stock Alerts - Newser
When is the best time to exit Alkermes plc2025 Market Outlook & Expert Curated Trade Setups - Newser
Identifying reversal signals in Alkermes plcMarket Growth Review & Free Technical Pattern Based Buy Signals - Newser
Can swing trading help recover from Alkermes plc lossesPortfolio Growth Summary & High Accuracy Trade Alerts - Newser
Using Bollinger Bands to evaluate Alkermes plcTrade Volume Report & AI Driven Stock Reports - Newser
How cyclical is Alkermes plc’s revenue streamJuly 2025 Weekly Recap & Technical Pattern Based Signals - khodrobank.com
Multi asset correlation models including Alkermes plcLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser
Analyzing recovery setups for Alkermes plc investorsWeekly Stock Summary & Daily Stock Trend Reports - Newser
How to track smart money flows in Alkermes plcJuly 2025 Market Mood & Weekly Setup with High ROI Potential - Newser
Does Alkermes plc qualify in momentum factor screening2025 Support & Resistance & Weekly Momentum Picks - Newser
Does Alkermes plc fit your quant trading modelQuarterly Earnings Summary & Low Risk Entry Point Guides - Newser
Alkermes plc (ALKS) Completes Enrollment in Key Narcolepsy Trial, Data Due Q3 2025 - Yahoo Finance
Visual trend scoring systems applied to Alkermes plcJuly 2025 Outlook & Reliable Intraday Trade Plans - Newser
How to manage a losing position in Alkermes plcWeekly Volume Report & Risk Managed Investment Strategies - Newser
Can Alkermes plc maintain sales growthWeekly Investment Recap & Reliable Breakout Stock Forecasts - khodrobank.com
Is Alkermes plc a top pick in the sectorCEO Change & Smart Money Movement Tracker - khodrobank.com
How Alkermes plc stock performs during market volatilityWeekly Trade Analysis & Accurate Technical Buy Alerts - Newser
Is Alkermes plc stock undervalued right now2025 Pullback Review & Fast Entry Momentum Alerts - khodrobank.com
Alkermes plc stock trend outlook and recovery pathEarnings Performance Report & Safe Capital Growth Trade Ideas - Newser
Sentiment analysis tools applied to Alkermes plcJuly 2025 WrapUp & Real-Time Market Sentiment Reports - Newser
How to read the order book for Alkermes plcShare Buyback & Fast Gain Stock Tips - Newser
Alkermes plc stock trend forecastExit Point & Weekly Watchlist of Top Performers - Newser
Will Alkermes plc benefit from macro trends2025 Macro Impact & AI Forecasted Stock Moves - Newser
Alkermes Plc Azioni (ALKS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.80%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):